← All stocks

AZN vs NVO

AstraZeneca PLC Ordinary Shares vs Novo Nordisk A/S Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
AZN
NVO
Composite score
Out of 100
59
63
Growth
40
19
Value
64
91
Quality
84
96
Momentum
47
45
Valuation
AZN
NVO
Price
168.10
39.80
Market cap
257.57B
191.03B
Trailing P/E
24.86
10.73
Forward P/E
14.45
13.33
EV / EBITDA
14.06
9.06
Dividend yield
1.9%
4.2%
Profitability
AZN
NVO
ROE
22.0%
59.8%
Net margin
17.0%
35.4%
Debt / equity
0.57
0.67
Free cash flow
8.67B
28.99B
Growth
AZN
NVO
Revenue growth (YoY)
6.4%
2.1%
Earnings growth (YoY)
2.5%
-20.6%
Analyst target
212.17
46.80
See full analysis